BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 24980070)

  • 1. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
    Latov N
    Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fisher syndrome and Bickerstaff brainstem encephalitis].
    Kuwabara S
    Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
    Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated neuropathies.
    Kieseier BC; Mathey EK; Sommer C; Hartung HP
    Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Immune-Mediated Polyneuropathies.
    Cox SZ; Gwathmey KG
    Clin Geriatr Med; 2021 May; 37(2):327-345. PubMed ID: 33858614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in chronic immune mediated neuropathies: a systematic review.
    Chaganti S; Hannaford A; Vucic S
    Neuromuscul Disord; 2022 Aug; 32(8):621-627. PubMed ID: 35672205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum of chronic acquired demyelinating polyneuropathies.
    Saperstein DS; Katz JS; Amato AA; Barohn RJ
    Muscle Nerve; 2001 Mar; 24(3):311-24. PubMed ID: 11353415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody].
    Motoyama R; Yamakawa K; Suzuki S; Kusunoki S; Tanaka M
    Rinsho Shinkeigaku; 2011 Oct; 51(10):761-4. PubMed ID: 22019868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies.
    Briani C; Visentin A
    Neurotherapeutics; 2022 Apr; 19(3):874-884. PubMed ID: 35349079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.
    Nobile-Orazio E; Gallia F; Terenghi F; Bianco M
    Expert Rev Neurother; 2017 Aug; 17(8):755-765. PubMed ID: 28597710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diagnostic score for anti-myelin-associated-glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti-myelin-associated-glycoprotein antibody.
    Doneddu PE; Ruiz M; Bianchi E; Liberatore G; Manganelli F; Cocito D; Cosentino G; Benedetti L; Marfia GA; Filosto M; Briani C; Giannotta C; Nobile-Orazio E
    Eur J Neurol; 2023 Feb; 30(2):501-510. PubMed ID: 35191144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on therapy of chronic immune-mediated neuropathies.
    Briani C; Cocito D; Campagnolo M; Doneddu PE; Nobile-Orazio E
    Neurol Sci; 2022 Dec; 43(Suppl 2):605-614. PubMed ID: 33452933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
    Franques J
    Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraproteinemia and neuropathy.
    Koike H; Katsuno M
    Neurol Sci; 2021 Nov; 42(11):4489-4501. PubMed ID: 34529193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].
    Kuwabara S
    Rinsho Shinkeigaku; 2024 May; 64(5):321-325. PubMed ID: 38644208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
    Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.